This is a Validated Antibody Database (VAD) review about mouse Fcer1a, based on 64 published articles (read how Labome selects the articles), using Fcer1a antibody in all methods. It is aimed to help Labome visitors find the most suited Fcer1a antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Fcer1a synonym: FcERI; Fce1a; Fcr-5; fcepsilonri

BioLegend
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; loading ...; fig s3
BioLegend Fcer1a antibody (BioLegend, 134308) was used in flow cytometry on mouse samples (fig s3). (2022) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; 1:750; loading ...; fig 7g
BioLegend Fcer1a antibody (BioLegend, 134317) was used in flow cytometry on mouse samples at 1:750 (fig 7g). J Clin Invest (2022) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; 1:200; loading ...; fig s1
BioLegend Fcer1a antibody (Biolegend, 134304) was used in flow cytometry on mouse samples at 1:200 (fig s1). Front Immunol (2021) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; 1:200; loading ...; fig s1j
BioLegend Fcer1a antibody (BioLegend, 134304) was used in flow cytometry on mouse samples at 1:200 (fig s1j). Nature (2021) ncbi
hamsters monoclonal (MAR-1)
BioLegend Fcer1a antibody (Biolegend, 134306) was used . Theranostics (2021) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; loading ...
BioLegend Fcer1a antibody (Biolegend, MAR-1) was used in flow cytometry on mouse samples . Antioxidants (Basel) (2020) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend Fcer1a antibody (Biolegend, Mar-1) was used in flow cytometry on mouse samples (fig 1a). Front Immunol (2020) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; loading ...
BioLegend Fcer1a antibody (Biolegend, MAR-1) was used in flow cytometry on mouse samples . elife (2020) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; loading ...; fig 3c, 5b
BioLegend Fcer1a antibody (Biolegend, MAR-1) was used in flow cytometry on mouse samples (fig 3c, 5b). elife (2020) ncbi
hamsters monoclonal (MAR-1)
  • mass cytometry; mouse; 1.5 ug/ml; loading ...; fig 5d
BioLegend Fcer1a antibody (Biolegend, MAR-1) was used in mass cytometry on mouse samples at 1.5 ug/ml (fig 5d). Science (2019) ncbi
hamsters monoclonal (MAR-1)
  • mass cytometry; mouse; loading ...; fig 3, s2
BioLegend Fcer1a antibody (Biolegend, 134321) was used in mass cytometry on mouse samples (fig 3, s2). Science (2019) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; loading ...; fig s1f
BioLegend Fcer1a antibody (BioLegend, 134316) was used in flow cytometry on mouse samples (fig s1f). Immunity (2019) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; loading ...; fig s4a
BioLegend Fcer1a antibody (BioLegend, 134308) was used in flow cytometry on mouse samples (fig s4a). J Clin Invest (2019) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; loading ...; fig s2
BioLegend Fcer1a antibody (Biolegend, MAR1) was used in flow cytometry on mouse samples (fig s2). Proc Natl Acad Sci U S A (2019) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; loading ...; fig s1
BioLegend Fcer1a antibody (Biolegend, MAR-1) was used in flow cytometry on mouse samples (fig s1). Science (2018) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; loading ...; fig 1b
BioLegend Fcer1a antibody (BioLegend, MAR-1) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2018) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; loading ...; fig s1h
In order to investigate the role of IL-4Ralpha-mediated macrophage activation promote in lung and liver wound repair, BioLegend Fcer1a antibody (BioLegend, MAR-1) was used in flow cytometry on mouse samples (fig s1h). Science (2017) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; fig 3a
BioLegend Fcer1a antibody (Biolegend, MAR-I) was used in flow cytometry on mouse samples (fig 3a). J Clin Invest (2017) ncbi
hamsters monoclonal (MAR-1)
  • immunohistochemistry - frozen section; mouse; 1:500; loading ...; fig 6c
  • flow cytometry; mouse; 1:100
In order to suggest that air-pollution-induced atopic dermatitis occurs through activation of AhR, BioLegend Fcer1a antibody (BioLegend, MAR-1) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig 6c) and in flow cytometry on mouse samples at 1:100. Nat Immunol (2017) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; loading ...; fig 5a
In order to use a humanized mouse model to study Middle East respiratory syndrome coronavirus, BioLegend Fcer1a antibody (BioLegend, MAR-1) was used in flow cytometry on mouse samples (fig 5a). J Virol (2017) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; loading ...; fig st1
In order to determine the contribution of IL-33 and ST2 to eosinophil homeostasis, BioLegend Fcer1a antibody (BioLegend, 1-Mar) was used in flow cytometry on mouse samples (fig st1). J Immunol (2016) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; loading ...
In order to investigate allergic responses to food allergens in WASP-deficient animals, BioLegend Fcer1a antibody (Biolegend, MAR-1) was used in flow cytometry on mouse samples . J Clin Invest (2016) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; 1:200; tbl 1
BioLegend Fcer1a antibody (Biolegend, Mar_1) was used in flow cytometry on mouse samples at 1:200 (tbl 1). Nat Commun (2016) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; fig s3
In order to demonstrate that OTULIN is essential for preventing TNF-associated systemic inflammation in humans and mice, BioLegend Fcer1a antibody (BioLegend, 134305) was used in flow cytometry on mouse samples (fig s3). Cell (2016) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; loading ...; fig 3d
In order to study how IL-17 and IFN-gamma control Staphylococcus aureus infection, BioLegend Fcer1a antibody (BioLegend, MAR1) was used in flow cytometry on mouse samples (fig 3d). Am J Pathol (2016) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; loading ...; fig s2b
BioLegend Fcer1a antibody (BioLegend, MAR-1) was used in flow cytometry on mouse samples (fig s2b). Mucosal Immunol (2017) ncbi
mouse monoclonal (TX61)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BioLegend Fcer1a antibody (BioLegen d, 137306) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; fig 2
BioLegend Fcer1a antibody (BioLegend, MAR-1) was used in flow cytometry on mouse samples (fig 2). J Biol Chem (2015) ncbi
mouse monoclonal (TX61)
  • flow cytometry; human; loading ...; fig 3a
BioLegend Fcer1a antibody (BioLegend, TX61) was used in flow cytometry on human samples (fig 3a). J Immunol (2015) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; fig s5
BioLegend Fcer1a antibody (Biolegend, MAR-1) was used in flow cytometry on mouse samples (fig s5). PLoS Pathog (2015) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; fig s1
  • flow cytometry; human; loading ...; fig 2b
In order to propose that basophils exert direct innate immune effector functions in the extracellular space, BioLegend Fcer1a antibody (BioLegend, MAR-1) was used in flow cytometry on mouse samples (fig s1) and in flow cytometry on human samples (fig 2b). J Immunol (2014) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse
BioLegend Fcer1a antibody (BioLegend, MAR-1) was used in flow cytometry on mouse samples . PLoS Pathog (2014) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; human
  • flow cytometry; mouse
In order to elucidate the immunological pathways that lead to obesity-associated asthma, BioLegend Fcer1a antibody (BioLegend, 134306) was used in flow cytometry on human samples and in flow cytometry on mouse samples . Nat Med (2014) ncbi
Invitrogen
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; 500 ug/ml; loading ...; fig 2e
Invitrogen Fcer1a antibody (Life Technology, 11-5898-85) was used in flow cytometry on mouse samples at 500 ug/ml (fig 2e). Sci Rep (2021) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; 1:1000; loading ...
Invitrogen Fcer1a antibody (eBioscience, MAR-1) was used in flow cytometry on mouse samples at 1:1000. Sci Rep (2021) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; 1:200; loading ...; fig s7
Invitrogen Fcer1a antibody (eBioscience, 17-5898-82) was used in flow cytometry on mouse samples at 1:200 (fig s7). Sci Immunol (2020) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; 1:800; loading ...; fig e3i
Invitrogen Fcer1a antibody (eBioscience, 12-5898-81) was used in flow cytometry on mouse samples at 1:800 (fig e3i). Nature (2019) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; loading ...; fig s2
Invitrogen Fcer1a antibody (Thermo Fisher, 25-5898-82) was used in flow cytometry on mouse samples (fig s2). Front Immunol (2018) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; loading ...; fig 3b
Invitrogen Fcer1a antibody (eBioscience, MAR-1) was used in flow cytometry on mouse samples (fig 3b). Nature (2018) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; 1:200; fig 3b
Invitrogen Fcer1a antibody (eBiosciences, MAR-1) was used in flow cytometry on mouse samples at 1:200 (fig 3b). J Allergy Clin Immunol (2018) ncbi
hamsters monoclonal (MAR-1)
  • blocking or activating experiments; mouse; loading ...; fig s1a
  • flow cytometry; mouse; fig s1a
In order to propose that type 2 immunity is induced by a unique mechanism in the genital tract, Invitrogen Fcer1a antibody (eBioscience, MAR-1) was used in blocking or activating experiments on mouse samples (fig s1a) and in flow cytometry on mouse samples (fig s1a). Proc Natl Acad Sci U S A (2017) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; loading ...
In order to report how steady-state plasma histamine levels are regulated and affected by environmental factors, Invitrogen Fcer1a antibody (eBioscience, MAR-1) was used in flow cytometry on mouse samples . Sci Rep (2017) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; fig 3a
In order to demonstrate that CD300f suppresses lipopolysaccharide-induced skin inflammation, Invitrogen Fcer1a antibody (eBiosciences, MAR-1) was used in flow cytometry on mouse samples (fig 3a). J Biol Chem (2017) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; 1:200; fig s13
In order to demonstrate that SAMHD1 reduces nucleoside analog cytarabine cytotoxicity in acute myeloid leukemia cells, Invitrogen Fcer1a antibody (eBioscience, 12-5898) was used in flow cytometry on mouse samples at 1:200 (fig s13). Nat Med (2017) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; loading ...; fig 2d
Invitrogen Fcer1a antibody (eBiosciences, MAR-1) was used in flow cytometry on mouse samples (fig 2d). Cancer Res (2017) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; loading ...; fig 3D
In order to show that deletion of the gene encoding RAB guanine nucleotide exchange factor 1 in keratinocytes severely impairs epidermal barrier function in mice, Invitrogen Fcer1a antibody (eBioscience, MAR-1) was used in flow cytometry on mouse samples (fig 3D). J Clin Invest (2016) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; loading ...
In order to assess the role of C1q in downregulating allergic inflammation, Invitrogen Fcer1a antibody (eBiosciences, MAR-1) was used in flow cytometry on mouse samples . Mucosal Immunol (2017) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; loading ...
In order to study the effect of IL-13 and IL-33 pathways in dysregulated type 2 inflammation., Invitrogen Fcer1a antibody (eBioscience, MAR-1) was used in flow cytometry on mouse samples . J Allergy Clin Immunol (2017) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse
In order to find a role for Car enzymes in regulating mast cell lineage commitment, Invitrogen Fcer1a antibody (eBioscience, MAR-1) was used in flow cytometry on mouse samples . J Exp Med (2016) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; fig 1g
In order to investigate the impact of ORMDL3 to the mast cell physiology, Invitrogen Fcer1a antibody (eBioscience, 11-5898) was used in flow cytometry on mouse samples (fig 1g). Cell Mol Life Sci (2016) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; loading ...; fig 2
In order to report a role for effector T helper type 2 cells during T cell receptor-independent innate-like immune responses, Invitrogen Fcer1a antibody (eBiosciences, MAR-1) was used in flow cytometry on mouse samples (fig 2). Nat Immunol (2015) ncbi
hamsters monoclonal (MAR-1)
  • immunohistochemistry; mouse; 1:50
Invitrogen Fcer1a antibody (eBioscience, 14 -5898- 82) was used in immunohistochemistry on mouse samples at 1:50. Endocrinology (2015) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; loading ...; fig s1
In order to discuss tissue tropisms of innate lymphoid cells, Invitrogen Fcer1a antibody (eBioscience, MAR-1) was used in flow cytometry on mouse samples (fig s1). Immunity (2015) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; tbl s1
In order to study the role of ICOS in group 2 innate lymphoid cell responses, Invitrogen Fcer1a antibody (eBiosciences, 1-Mar) was used in flow cytometry on mouse samples (tbl s1). Biochem Biophys Res Commun (2015) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse
Invitrogen Fcer1a antibody (eBioscience, MAR-1) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2014) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; 1:300
Invitrogen Fcer1a antibody (eBioscience, MAR-1) was used in flow cytometry on mouse samples at 1:300. Methods Mol Biol (2015) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse
Invitrogen Fcer1a antibody (eBioscience, MAR-1) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; 10 ug/ml; fig 2b
In order to discuss how IgE titers mediate food-induced anaphylaxis, Invitrogen Fcer1a antibody (Affymetrix eBioscience, MAR-1) was used in flow cytometry on mouse samples at 10 ug/ml (fig 2b). J Allergy Clin Immunol (2014) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse
Invitrogen Fcer1a antibody (eBioscience, MAR-1) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse
Invitrogen Fcer1a antibody (eBiosceince, MAR-1) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse
Invitrogen Fcer1a antibody (eBioscience, MAR-1) was used in flow cytometry on mouse samples . Mol Cell Biol (2012) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse; fig 1
Invitrogen Fcer1a antibody (eBioscience, MAR1) was used in flow cytometry on mouse samples (fig 1). J Immunol (2010) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse
In order to examine the role of naturally occurring regulatory dendritic cells in a mouse model of chronic graft-versus-host disease, Invitrogen Fcer1a antibody (eBioscience, MAR-1) was used in flow cytometry on mouse samples . Blood (2009) ncbi
hamsters monoclonal (MAR-1)
  • flow cytometry; mouse
In order to examine the role of IL-25 during Nippostrongylus brasiliensis infection, Invitrogen Fcer1a antibody (eBioscience, MAR-1) was used in flow cytometry on mouse samples . J Exp Med (2006) ncbi
Articles Reviewed
  1. Piliponsky A, Sharma K, Quach P, Brokaw A, Nguyen S, Orvis A, et al. Mast cell-derived factor XIIIA contributes to sexual dimorphic defense against group B streptococcal infections. J Clin Invest. 2022;132: pubmed publisher
  2. Lees Shepard J, Stoessel S, Chandler J, Bouchard K, Bento P, Apuzzo L, et al. An anti-ACVR1 antibody exacerbates heterotopic ossification by fibro-adipogenic progenitors in fibrodysplasia ossificans progressiva mice. J Clin Invest. 2022;132: pubmed publisher
  3. Patial S, Lewis B, Vo T, Choudhary I, Paudel K, Mao Y, et al. Myeloid-IL4Rα is an indispensable link in IL-33-ILCs-IL-13-IL4Rα axis of eosinophil recruitment in murine lungs. Sci Rep. 2021;11:15465 pubmed publisher
  4. Okamura T, Hashimoto Y, Mori J, Yamaguchi M, Majima S, Senmaru T, et al. ILC2s Improve Glucose Metabolism Through the Control of Saturated Fatty Acid Absorption Within Visceral Fat. Front Immunol. 2021;12:669629 pubmed publisher
  5. Phong B, D Souza S, Baudier R, Wu E, Immethun V, Bauer D, et al. IgE-activated mast cells enhance TLR4-mediated antigen-specific CD4+ T cell responses. Sci Rep. 2021;11:9686 pubmed publisher
  6. Bielecki P, Riesenfeld S, Hütter J, Torlai Triglia E, Kowalczyk M, Ricardo Gonzalez R, et al. Skin-resident innate lymphoid cells converge on a pathogenic effector state. Nature. 2021;592:128-132 pubmed publisher
  7. Chen W, Wu Y, Tsai T, Li R, Lai A, Li L, et al. Group 2 innate lymphoid cells contribute to IL-33-mediated alleviation of cardiac fibrosis. Theranostics. 2021;11:2594-2611 pubmed publisher
  8. Yoon S, Song S, Shin J, Kang S, Kim H, You H. Protective Effects of Korean Herbal Remedy against Airway Inflammation in an Allergic Asthma by Suppressing Eosinophil Recruitment and Infiltration in Lung. Antioxidants (Basel). 2020;10: pubmed publisher
  9. Katano I, Ito R, Kawai K, Takahashi T. Improved Detection of in vivo Human NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Using a Novel NOG-FcγR-Deficient Human IL-15 Transgenic Mouse. Front Immunol. 2020;11:532684 pubmed publisher
  10. Tizian C, Lahmann A, Hölsken O, Cosovanu C, Kofoed Branzk M, Heinrich F, et al. c-Maf restrains T-bet-driven programming of CCR6-negative group 3 innate lymphoid cells. elife. 2020;9: pubmed publisher
  11. Hayes M, Ward S, Crawford G, Seoane R, Jackson W, Kipling D, et al. Inflammation-induced IgE promotes epithelial hyperplasia and tumour growth. elife. 2020;9: pubmed publisher
  12. Asrat S, Kaur N, Liu X, Ben L, Kajimura D, Murphy A, et al. Chronic allergen exposure drives accumulation of long-lived IgE plasma cells in the bone marrow, giving rise to serological memory. Sci Immunol. 2020;5: pubmed publisher
  13. Guo C, Allen B, Hiam K, Dodd D, Van Treuren W, Higginbottom S, et al. Depletion of microbiome-derived molecules in the host using Clostridium genetics. Science. 2019;366: pubmed publisher
  14. Rosshart S, Herz J, Vassallo B, Hunter A, Wall M, Badger J, et al. Laboratory mice born to wild mice have natural microbiota and model human immune responses. Science. 2019;365: pubmed publisher
  15. Wilkinson A, Ishida R, Kikuchi M, Sudo K, Morita M, Crisostomo R, et al. Long-term ex vivo haematopoietic-stem-cell expansion allows nonconditioned transplantation. Nature. 2019;: pubmed publisher
  16. Janela B, Patel A, Lau M, Goh C, Msallam R, Kong W, et al. A Subset of Type I Conventional Dendritic Cells Controls Cutaneous Bacterial Infections through VEGFα-Mediated Recruitment of Neutrophils. Immunity. 2019;50:1069-1083.e8 pubmed publisher
  17. Mantri C, St John A. Immune synapses between mast cells and γδ T cells limit viral infection. J Clin Invest. 2019;129:1094-1108 pubmed publisher
  18. Kaplanov I, Carmi Y, Kornetsky R, Shemesh A, Shurin G, Shurin M, et al. Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation. Proc Natl Acad Sci U S A. 2019;116:1361-1369 pubmed publisher
  19. Choi H, Suwanpradid J, Kim I, Staats H, Haniffa M, Macleod A, et al. Perivascular dendritic cells elicit anaphylaxis by relaying allergens to mast cells via microvesicles. Science. 2018;362: pubmed publisher
  20. Adam L, Lopez Gonzalez M, Björk A, Pålsson S, Poux C, Wahren Herlenius M, et al. Early Resistance of Non-virulent Mycobacterial Infection in C57BL/6 Mice Is Associated With Rapid Up-Regulation of Antimicrobial Cathelicidin Camp. Front Immunol. 2018;9:1939 pubmed publisher
  21. Huang L, Nazarova E, Tan S, Liu Y, Russell D. Growth of Mycobacterium tuberculosis in vivo segregates with host macrophage metabolism and ontogeny. J Exp Med. 2018;215:1135-1152 pubmed publisher
  22. Garaycoechea J, Crossan G, Langevin F, Mulderrig L, Louzada S, Yang F, et al. Alcohol and endogenous aldehydes damage chromosomes and mutate stem cells. Nature. 2018;553:171-177 pubmed publisher
  23. Wang H, Do D, Liu J, Wang B, Qu J, Ke X, et al. Functional role of kynurenine and aryl hydrocarbon receptor axis in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2018;141:586-600.e6 pubmed publisher
  24. Minutti C, Jackson Jones L, Garcia Fojeda B, Knipper J, Sutherland T, Logan N, et al. Local amplifiers of IL-4R?-mediated macrophage activation promote repair in lung and liver. Science. 2017;356:1076-1080 pubmed publisher
  25. Lee H, Tian L, Bouladoux N, Davis J, Quinones M, Belkaid Y, et al. Dendritic cells expressing immunoreceptor CD300f are critical for controlling chronic gut inflammation. J Clin Invest. 2017;127:1905-1917 pubmed publisher
  26. Oh J, Oh D, Jung H, Lee H. A mechanism for the induction of type 2 immune responses by a protease allergen in the genital tract. Proc Natl Acad Sci U S A. 2017;114:E1188-E1195 pubmed publisher
  27. Nakamura Y, Ishimaru K, Shibata S, Nakao A. Regulation of plasma histamine levels by the mast cell clock and its modulation by stress. Sci Rep. 2017;7:39934 pubmed publisher
  28. Shiba E, Izawa K, Kaitani A, Isobe M, Maehara A, Uchida K, et al. Ceramide-CD300f Binding Inhibits Lipopolysaccharide-induced Skin Inflammation. J Biol Chem. 2017;292:2924-2932 pubmed publisher
  29. Schneider C, Oellerich T, Baldauf H, Schwarz S, Thomas D, Flick R, et al. SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia. Nat Med. 2017;23:250-255 pubmed publisher
  30. Sektioglu I, Carretero R, Bulbuc N, Bald T, Tüting T, Rudensky A, et al. Basophils Promote Tumor Rejection via Chemotaxis and Infiltration of CD8+ T Cells. Cancer Res. 2017;77:291-302 pubmed publisher
  31. Hidaka T, Ogawa E, Kobayashi E, Suzuki T, Funayama R, Nagashima T, et al. The aryl hydrocarbon receptor AhR links atopic dermatitis and air pollution via induction of the neurotrophic factor artemin. Nat Immunol. 2017;18:64-73 pubmed publisher
  32. Marichal T, Gaudenzio N, El Abbas S, Sibilano R, Zurek O, Starkl P, et al. Guanine nucleotide exchange factor RABGEF1 regulates keratinocyte-intrinsic signaling to maintain skin homeostasis. J Clin Invest. 2016;126:4497-4515 pubmed publisher
  33. Coleman C, Sisk J, Halasz G, Zhong J, Beck S, Matthews K, et al. CD8+ T Cells and Macrophages Regulate Pathogenesis in a Mouse Model of Middle East Respiratory Syndrome. J Virol. 2017;91: pubmed publisher
  34. Mascarell L, Airouche S, Berjont N, Gary C, Gueguen C, Fourcade G, et al. The regulatory dendritic cell marker C1q is a potent inhibitor of allergic inflammation. Mucosal Immunol. 2017;10:695-704 pubmed publisher
  35. Ramirez Carrozzi V, Sambandam A, Zhou M, Yan D, Kang J, Wu X, et al. Combined blockade of the IL-13 and IL-33 pathways leads to a greater inhibition of type 2 inflammation over inhibition of either pathway alone. J Allergy Clin Immunol. 2017;139:705-708.e6 pubmed publisher
  36. Johnston L, Hsu C, Krier Burris R, Chhiba K, Chien K, McKenzie A, et al. IL-33 Precedes IL-5 in Regulating Eosinophil Commitment and Is Required for Eosinophil Homeostasis. J Immunol. 2016;197:3445-3453 pubmed
  37. Lexmond W, Goettel J, Lyons J, Jacobse J, Deken M, Lawrence M, et al. FOXP3+ Tregs require WASP to restrain Th2-mediated food allergy. J Clin Invest. 2016;126:4030-4044 pubmed publisher
  38. Jackson Jones L, Duncan S, Magalhaes M, Campbell S, Maizels R, McSorley H, et al. Fat-associated lymphoid clusters control local IgM secretion during pleural infection and lung inflammation. Nat Commun. 2016;7:12651 pubmed publisher
  39. Henry E, Sy C, Inclan Rico J, Espinosa V, Ghanny S, Dwyer D, et al. Carbonic anhydrase enzymes regulate mast cell-mediated inflammation. J Exp Med. 2016;213:1663-73 pubmed publisher
  40. Damgaard R, Walker J, Marco Casanova P, Morgan N, Titheradge H, Elliott P, et al. The Deubiquitinase OTULIN Is an Essential Negative Regulator of Inflammation and Autoimmunity. Cell. 2016;166:1215-1230.e20 pubmed publisher
  41. Barin J, Talor M, Schaub J, Diny N, Hou X, Hoyer M, et al. Collaborative Interferon-? and Interleukin-17 Signaling Protects the Oral Mucosa from Staphylococcus aureus. Am J Pathol. 2016;186:2337-52 pubmed publisher
  42. Damle S, Martin R, Cross J, Conrad D. Macrophage migration inhibitory factor deficiency enhances immune response to Nippostrongylus brasiliensis. Mucosal Immunol. 2017;10:205-214 pubmed publisher
  43. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  44. Bugajev V, Hálová I, Dráberová L, Bambousková M, Potůčková L, Draberova H, et al. Negative regulatory roles of ORMDL3 in the FcεRI-triggered expression of proinflammatory mediators and chemotactic response in murine mast cells. Cell Mol Life Sci. 2016;73:1265-85 pubmed publisher
  45. Guo L, Huang Y, Chen X, Hu Li J, Urban J, Paul W. Innate immunological function of TH2 cells in vivo. Nat Immunol. 2015;16:1051-9 pubmed publisher
  46. Lee Y, Liu C, Liao M, Sukhova G, Shirakawa J, Abdennour M, et al. Deficiency of FcϵR1 Increases Body Weight Gain but Improves Glucose Tolerance in Diet-Induced Obese Mice. Endocrinology. 2015;156:4047-58 pubmed publisher
  47. Kim M, Taparowsky E, Kim C. Retinoic Acid Differentially Regulates the Migration of Innate Lymphoid Cell Subsets to the Gut. Immunity. 2015;43:107-19 pubmed publisher
  48. Kamachi F, Isshiki T, Harada N, Akiba H, Miyake S. ICOS promotes group 2 innate lymphoid cell activation in lungs. Biochem Biophys Res Commun. 2015;463:739-45 pubmed publisher
  49. Di C, Lin X, Zhang Y, Zhong W, Yuan Y, Zhou T, et al. Basophil-associated OX40 ligand participates in the initiation of Th2 responses during airway inflammation. J Biol Chem. 2015;290:12523-36 pubmed publisher
  50. Anquetil F, Clavel C, Offer G, Serre G, Sebbag M. IgM and IgA rheumatoid factors purified from rheumatoid arthritis sera boost the Fc receptor- and complement-dependent effector functions of the disease-specific anti-citrullinated protein autoantibodies. J Immunol. 2015;194:3664-74 pubmed publisher
  51. Wiesner D, Specht C, Lee C, Smith K, Mukaremera L, Lee S, et al. Chitin recognition via chitotriosidase promotes pathologic type-2 helper T cell responses to cryptococcal infection. PLoS Pathog. 2015;11:e1004701 pubmed publisher
  52. Schwartz C, Turqueti Neves A, Hartmann S, Yu P, Nimmerjahn F, Voehringer D. Basophil-mediated protection against gastrointestinal helminths requires IgE-induced cytokine secretion. Proc Natl Acad Sci U S A. 2014;111:E5169-77 pubmed publisher
  53. Peschke K, Dudeck A, Rabenhorst A, Hartmann K, Roers A. Cre/loxP-based mouse models of mast cell deficiency and mast cell-specific gene inactivation. Methods Mol Biol. 2015;1220:403-21 pubmed publisher
  54. Schwartz C, Oeser K, Prazeres da Costa C, Layland L, Voehringer D. T cell-derived IL-4/IL-13 protects mice against fatal Schistosoma mansoni infection independently of basophils. J Immunol. 2014;193:3590-9 pubmed publisher
  55. Burton O, Logsdon S, Zhou J, Medina Tamayo J, Abdel Gadir A, Noval Rivas M, et al. Oral immunotherapy induces IgG antibodies that act through Fc?RIIb to suppress IgE-mediated hypersensitivity. J Allergy Clin Immunol. 2014;134:1310-1317.e6 pubmed publisher
  56. Fukuishi N, Murakami S, Ohno A, Yamanaka N, Matsui N, Fukutsuji K, et al. Does ?-hexosaminidase function only as a degranulation indicator in mast cells? The primary role of ?-hexosaminidase in mast cell granules. J Immunol. 2014;193:1886-94 pubmed publisher
  57. Morshed M, Hlushchuk R, Simon D, Walls A, Obata Ninomiya K, Karasuyama H, et al. NADPH oxidase-independent formation of extracellular DNA traps by basophils. J Immunol. 2014;192:5314-23 pubmed publisher
  58. Ebert S, Becker M, Lemmermann N, Büttner J, Michel A, Taube C, et al. Mast cells expedite control of pulmonary murine cytomegalovirus infection by enhancing the recruitment of protective CD8 T cells to the lungs. PLoS Pathog. 2014;10:e1004100 pubmed publisher
  59. Sheng K, Herrero L, Taylor A, Hapel A, Mahalingam S. IL-3 and CSF-1 interact to promote generation of CD11c+ IL-10-producing macrophages. PLoS ONE. 2014;9:e95208 pubmed publisher
  60. Kim H, Lee H, Chang Y, Pichavant M, Shore S, Fitzgerald K, et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med. 2014;20:54-61 pubmed publisher
  61. Ohmori S, Takai J, Ishijima Y, Suzuki M, Moriguchi T, Philipsen S, et al. Regulation of GATA factor expression is distinct between erythroid and mast cell lineages. Mol Cell Biol. 2012;32:4742-55 pubmed publisher
  62. Kim S, Prout M, Ramshaw H, Lopez A, LeGros G, Min B. Cutting edge: basophils are transiently recruited into the draining lymph nodes during helminth infection via IL-3, but infection-induced Th2 immunity can develop without basophil lymph node recruitment or IL-3. J Immunol. 2010;184:1143-7 pubmed publisher
  63. Sato K, Eizumi K, Fukaya T, Fujita S, Sato Y, Takagi H, et al. Naturally occurring regulatory dendritic cells regulate murine cutaneous chronic graft-versus-host disease. Blood. 2009;113:4780-9 pubmed publisher
  64. Fallon P, Ballantyne S, Mangan N, Barlow J, Dasvarma A, Hewett D, et al. Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J Exp Med. 2006;203:1105-16 pubmed